Welcome to hiintermediates.com,intermediates trading platform
Home > products > ADRIAMYCIN

ADRIAMYCIN cas no:29042-30-6

Synonyms: Adriamycin;doxorubicin;Doxorubicine;Adriablastin;Adriblastina;Doxorubicinum;Adriblastin;Doxil;Doxorubicina;14-Hydroxydaunomycin;Adriamycin semiquinone;14-Hydroxydaunorubicine;Doxorubicine [INN-French];Doxorubicinum [INN-Latin];Rubex;Doxorubicina [INN-Spanish];Adriamycin PFS;Adriamycin RDF;Resmycin;Myocet;ThermoDox;Adriblas tina;Doxorubicin-hLL1;23214-92-8;RDF Rubex;FI 106;Adriblastina (TN);CCRIS 739;CHEBI:28748;Aerosolized Doxorubicin;Doxorubicin-P4/D10;HSDB 3070;DOX-SL;NCI-C01514;Prestwick0_000438;Prestwick1_000438;Prestwick2_000438;Prestwick3_000438;EINECS 245-495-6;Doxorubicin (USAN/INN);Doxorubicin-hLL1 conjugate;Probes1_000151;Probes2_000129;Rubex (hydrochloride salt);NSC 123127;AC1L1M5T;AC1Q29OJ;BSPBio_000456;BSPBio_001031;Adriacin (hydrochloride salt);NDC 38242-874;SPBio_002395;Doxorubicin [USAN:INN:BAN];Doxorubicin Hydrochloride;Doxorubicin-P4/D10 conjugate;TLC D-99;BPBio1_000502;ADM;adiblastine (hydrochloride salt);adriblatina (hydrochloride salt);adriablatina (hydrochloride salt);Adriblastina (hydrochloride salt);adriablastine (hydrochloride salt);Farmablastina (hydrochloride salt);25316-40-9 (hydrochloride);adr iablatina (hydrochloride salt);C27H29NO11;HMS2089H06;UNII-80168379AG;Adriamycin PFS (hydrochloride salt);Adriamycin RDF (hydrochloride salt);LMPK13050001;DB00997;DM2;LS-1029;SMP1_000106;Doxorubicin citrate;LS-165655;Doxorubicin hydrochloride (hydrochloride salt);C01661;D03899;Triferric doxorubicin;Hydroxydaunomycin hydrochloride (hydrochloride salt);BRD-K92093830-003-04-3;Hydroxydaunomycin hydrochlor ide (hydrochloride salt);Hydroxydaunorubicin hydrochloride (hydrochloride salt);MLS000759533;Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74;Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;(1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-(3-amino-2,3,6-tridesoxy-alpha-L-lyxo-hexopyranosid);(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;1,2,3,4,6,11-Hexahydro-4beta,5,12-trihydroxy-4-(hydroxyacetyl)-10-methoxy-6,11-dioxonaphthacen-1beta-yl-3-amino-2,3,6-trideoxy-alpha-L-lyxohexopyranoside;10-((3-Amino-2,3,6-trideoxy-D-lyxohexopyranosyl)oxy)-8-glycolcyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;23257-17-2;24385-08-8;25311-50-6;29042-30-6;5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-;CHEMBL179;NIOSH/JT9100000;(8S,10S)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;CID31703;nchembio809-comp5;111266-55-8;ADR;CHEMBL53463;NChemBio.2007.10-comp13;DAP000192;DNC000163;NCGC00024415-35;NCGC00024415-37;NCGC00024415-38;NCGC00024415-39;NCGC00024415-40;NCGC00024415-41;NCGC00024415-42;AB1009243;JT9100000;TX-012225;10336-EP2270008A1;10336-EP2270014A1;10336-EP2270018A1;10336-EP2270505A1;10336-EP2272827A1;10336-EP2272832A1;10336-EP2275420A1;10336-EP2277565A2;10336-EP2277566A2;10336-EP2277567A1;10336-EP2277568A2;10336-EP2277569A2;10336-EP2277570A2;10336-EP2277865A1;10336-EP2277876A1;10336-EP2280012A2;10336-EP2281815A1;10336-EP2289892A1;10336-EP2292280A1;10336-EP2292614A1;

Directory

Identification
NameADRIAMYCIN
CAS29042-30-6
SynonymsAdriamycin;doxorubicin;Doxorubicine;Adriablastin;Adriblastina;Doxorubicinum;Adriblastin;Doxil;Doxorubicina;14-Hydroxydaunomycin;Adriamycin semiquinone;14-Hydroxydaunorubicine;Doxorubicine [INN-French];Doxorubicinum [INN-Latin];Rubex;Doxorubicina [INN-Spanish];Adriamycin PFS;Adriamycin RDF;Resmycin;Myocet;ThermoDox;Adriblas tina;Doxorubicin-hLL1;23214-92-8;RDF Rubex;FI 106;Adriblastina (TN);CCRIS 739;CHEBI:28748;Aerosolized Doxorubicin;Doxorubicin-P4/D10;HSDB 3070;DOX-SL;NCI-C01514;Prestwick0_000438;Prestwick1_000438;Prestwick2_000438;Prestwick3_000438;EINECS 245-495-6;Doxorubicin (USAN/INN);Doxorubicin-hLL1 conjugate;Probes1_000151;Probes2_000129;Rubex (hydrochloride salt);NSC 123127;AC1L1M5T;AC1Q29OJ;BSPBio_000456;BSPBio_001031;Adriacin (hydrochloride salt);NDC 38242-874;SPBio_002395;Doxorubicin [USAN:INN:BAN];Doxorubicin Hydrochloride;Doxorubicin-P4/D10 conjugate;TLC D-99;BPBio1_000502;ADM;adiblastine (hydrochloride salt);adriblatina (hydrochloride salt);adriablatina (hydrochloride salt);Adriblastina (hydrochloride salt);adriablastine (hydrochloride salt);Farmablastina (hydrochloride salt);25316-40-9 (hydrochloride);adr iablatina (hydrochloride salt);C27H29NO11;HMS2089H06;UNII-80168379AG;Adriamycin PFS (hydrochloride salt);Adriamycin RDF (hydrochloride salt);LMPK13050001;DB00997;DM2;LS-1029;SMP1_000106;Doxorubicin citrate;LS-165655;Doxorubicin hydrochloride (hydrochloride salt);C01661;D03899;Triferric doxorubicin;Hydroxydaunomycin hydrochloride (hydrochloride salt);BRD-K92093830-003-04-3;Hydroxydaunomycin hydrochlor ide (hydrochloride salt);Hydroxydaunorubicin hydrochloride (hydrochloride salt);MLS000759533;Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74;Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;(1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-(3-amino-2,3,6-tridesoxy-alpha-L-lyxo-hexopyranosid);(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;1,2,3,4,6,11-Hexahydro-4beta,5,12-trihydroxy-4-(hydroxyacetyl)-10-methoxy-6,11-dioxonaphthacen-1beta-yl-3-amino-2,3,6-trideoxy-alpha-L-lyxohexopyranoside;10-((3-Amino-2,3,6-trideoxy-D-lyxohexopyranosyl)oxy)-8-glycolcyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;23257-17-2;24385-08-8;25311-50-6;29042-30-6;5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-;CHEMBL179;NIOSH/JT9100000;(8S,10S)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;CID31703;nchembio809-comp5;111266-55-8;ADR;CHEMBL53463;NChemBio.2007.10-comp13;DAP000192;DNC000163;NCGC00024415-35;NCGC00024415-37;NCGC00024415-38;NCGC00024415-39;NCGC00024415-40;NCGC00024415-41;NCGC00024415-42;AB1009243;JT9100000;TX-012225;10336-EP2270008A1;10336-EP2270014A1;10336-EP2270018A1;10336-EP2270505A1;10336-EP2272827A1;10336-EP2272832A1;10336-EP2275420A1;10336-EP2277565A2;10336-EP2277566A2;10336-EP2277567A1;10336-EP2277568A2;10336-EP2277569A2;10336-EP2277570A2;10336-EP2277865A1;10336-EP2277876A1;10336-EP2280012A2;10336-EP2281815A1;10336-EP2289892A1;10336-EP2292280A1;10336-EP2292614A1;
Molecular Formula C27H29NO11
Molecular Weight0

supplier list

Zhishang Biological Technology Co.,Ltd.
Tel:86-171-81008617
Address: East Huacheng Road,NO.203,Jintan City,Changzhou City,Jiangsu Province

Home   |   About Us   |   Service   |   Links   |   Add to  Favorite

Copyright©2011 HiIntermediates ICP: B2-20090288 浙ICP备09045134号-49
Tel: +86-0571-89739792